Evidence map›Paper›PMID 38768145›Full record

ArticlePloS one2024

Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.

Masaya Yoshimura, Youko Honda, Emi Yonemitsu, Kasumi Kuraoka, Kiyotaka Suenaga

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Masaya YoshimuraResearch & Development Department, Research & Development Section, Meiji Animal Health Co., Ltd., Kumamoto, Japan.ORCID 0000-0002-4593-4902
Youko HondaResearch & Development Department, Research & Development Section, Meiji Animal Health Co., Ltd., Kumamoto, Japan.
Emi YonemitsuResearch & Development Department, Research & Development Section, Meiji Animal Health Co., Ltd., Kumamoto, Japan.
Kasumi KuraokaResearch & Development Department, Research & Development Section, Meiji Animal Health Co., Ltd., Kumamoto, Japan.
Kiyotaka SuenagaResearch & Development Department, Research & Development Section, Meiji Animal Health Co., Ltd., Kumamoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Swine atrophic rhinitis is a disease caused by Pasteurella multocida and Bordetella bronchiseptica that affects pigs. Inactivated vaccines containing the toxins produced by Pasteurella multocida and Bordetella bronchiseptica have been widely used for the prevention of swine atrophic rhinitis. The efficacy of a vaccine is correlated with the amount of antigen present; however, the protective toxin of P. multocida bound to aluminum hydroxide, which is used as an adjuvant, can hinder the monitoring of the antigen concentration in the vaccine. This study assessed the applicability of a dot immunoassay as an antigen quantification method using monoclonal antibodies. This quantification method was able to detect the antigen with high specificity and sensitivity even when the antigen was bound to the adjuvant, and its application to vaccine products revealed a correlation between the amount of antigen present in the vaccine and the neutralizing antibody titers induced in pigs. The antigen quantification method presented in this study is a simple and sensitive assay capable of quantifying the amount of antigen present in a vaccine that can be used as an alternative quality control measure.

Indexed as

Adjuvants, ImmunologicAluminum HydroxideAntigens, BacterialBacterial VaccinesPasteurella multocidaRhinitis, AtrophicSwine DiseasesAnimalsAntibodies, BacterialAntibodies, NeutralizingBordetella bronchisepticaPasteurella InfectionsSwineAdjuvants, ImmunologicAluminum HydroxideAntibodies, BacterialAntibodies, NeutralizingAntigens, BacterialBacterial Vaccines

Identifiers

PMID38768145
PMCPMC11104628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.